Correlates of Protection for M Protein-Based Vaccines against Group A Streptococcus

Area of Science:

• Microbiology
• Immunology
• Vaccinology

Background:

• Group A Streptococcus (GAS) is a significant global pathogen responsible for diverse infections, ranging from mild pharyngitis to severe invasive diseases and autoimmune complications like rheumatic heart disease.
• Despite its substantial impact on public health, an effective vaccine against GAS remains unavailable, hindering efforts to control its widespread morbidity and mortality.

Purpose of the Study:

• To review current immunoassays used for GAS and other pathogens.
• To identify challenges in implementing these immunoassays and propose future directions.
• To facilitate the development of M protein-based GAS vaccines by defining correlates of protection.

Main Methods:

• Comprehensive literature review of existing immunoassays for GAS and related bacterial species.
• Analysis of challenges and limitations in current immunoassay standardization and application.
• Exploration of potential strategies for identifying human correlates of protection.

Main Results:

• Current immunoassays for GAS lack standardization, posing a significant hurdle for vaccine development.
• Defining reliable correlates of protection is crucial for advancing GAS vaccine efficacy.
• M protein-based vaccines are the primary candidates, but their development requires improved immunological assays.

Conclusions:

• Standardization of immunoassays and identification of correlates of protection are critical next steps for developing an efficacious GAS vaccine.
• Addressing these challenges will accelerate the development of M protein-based vaccines.
• Further research into immunological responses is needed to overcome existing obstacles in GAS vaccine development.